298 related articles for article (PubMed ID: 30953863)
1. Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia.
Al Shweiki MR; Steinacker P; Oeckl P; Hengerer B; Danek A; Fassbender K; Diehl-Schmid J; Jahn H; Anderl-Straub S; Ludolph AC; Schönfeldt-Lecuona C; Otto M
J Psychiatr Res; 2019 Jun; 113():137-140. PubMed ID: 30953863
[TBL] [Abstract][Full Text] [Related]
2. Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders.
Katisko K; Cajanus A; Jääskeläinen O; Kontkanen A; Hartikainen P; Korhonen VE; Helisalmi S; Haapasalo A; Koivumaa-Honkanen H; Herukka SK; Remes AM; Solje E
J Neurol; 2020 Jan; 267(1):162-167. PubMed ID: 31595378
[TBL] [Abstract][Full Text] [Related]
3. Plasma neurofilament light in behavioural variant frontotemporal dementia compared to mood and psychotic disorders.
Eratne D; Kang M; Malpas C; Simpson-Yap S; Lewis C; Dang C; Grewal J; Coe A; Dobson H; Keem M; Chiu WH; Kalincik T; Ooi S; Darby D; Brodtmann A; Hansson O; Janelidze S; Blennow K; Zetterberg H; Walker A; Dean O; Berk M; Wannan C; Pantelis C; Loi SM; Walterfang M; Berkovic SF; Santillo AF; Velakoulis D
Aust N Z J Psychiatry; 2024 Jan; 58(1):70-81. PubMed ID: 37477141
[TBL] [Abstract][Full Text] [Related]
4. Serum neurofilament light chain in behavioral variant frontotemporal dementia.
Steinacker P; Anderl-Straub S; Diehl-Schmid J; Semler E; Uttner I; von Arnim CAF; Barthel H; Danek A; Fassbender K; Fliessbach K; Foerstl H; Grimmer T; Huppertz HJ; Jahn H; Kassubek J; Kornhuber J; Landwehrmeyer B; Lauer M; Maler JM; Mayer B; Oeckl P; Prudlo J; Schneider A; Volk AE; Wiltfang J; Schroeter ML; Ludolph AC; Otto M;
Neurology; 2018 Oct; 91(15):e1390-e1401. PubMed ID: 30209235
[TBL] [Abstract][Full Text] [Related]
5. Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders.
Ducharme S; Dols A; Laforce R; Devenney E; Kumfor F; van den Stock J; Dallaire-Théroux C; Seelaar H; Gossink F; Vijverberg E; Huey E; Vandenbulcke M; Masellis M; Trieu C; Onyike C; Caramelli P; de Souza LC; Santillo A; Waldö ML; Landin-Romero R; Piguet O; Kelso W; Eratne D; Velakoulis D; Ikeda M; Perry D; Pressman P; Boeve B; Vandenberghe R; Mendez M; Azuar C; Levy R; Le Ber I; Baez S; Lerner A; Ellajosyula R; Pasquier F; Galimberti D; Scarpini E; van Swieten J; Hornberger M; Rosen H; Hodges J; Diehl-Schmid J; Pijnenburg Y
Brain; 2020 Jun; 143(6):1632-1650. PubMed ID: 32129844
[TBL] [Abstract][Full Text] [Related]
6. The overlap of symptomatic dimensions between frontotemporal dementia and several psychiatric disorders that appear in late adulthood.
Pose M; Cetkovich M; Gleichgerrcht E; Ibáñez A; Torralva T; Manes F
Int Rev Psychiatry; 2013 Apr; 25(2):159-67. PubMed ID: 23611346
[TBL] [Abstract][Full Text] [Related]
7. Plasma Neurofilament Light Chain and Clinical Diagnosis in Frontotemporal Dementia Syndromes.
Ooi S; Patel SK; Eratne D; Kyndt C; Reidy N; Lewis C; Lee SCM; Darby D; Brodtmann A
J Alzheimers Dis; 2022; 89(4):1221-1231. PubMed ID: 35988220
[TBL] [Abstract][Full Text] [Related]
8. Cognitive Deficits in Patients With Neuropsychiatric Symptoms: A Comparative Study Between Behavioral Variant Frontotemporal Dementia and Primary Psychiatric Disorders.
Vijverberg EGB; Schouws S; Meesters PD; Verwijk E; Comijs H; Koene T; Schreuder C; Beekman A; Scheltens P; Stek M; Pijnenburg Y; Dols A
J Clin Psychiatry; 2017; 78(8):e940-e946. PubMed ID: 28749089
[TBL] [Abstract][Full Text] [Related]
9. Disease trajectories in behavioural variant frontotemporal dementia, primary psychiatric and other neurodegenerative disorders presenting with behavioural change.
Reus LM; Vijverberg EG; Tijms BM; Kate MT; Gossink F; Krudop WA; Campo MD; Teunissen CE; Barkhof F; van der Flier WM; Visser PJ; Dols A; Pijnenburg YA
J Psychiatr Res; 2018 Sep; 104():183-191. PubMed ID: 30103065
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid neurofilament light chain differentiates behavioural variant frontotemporal dementia progressors from non-progressors.
Eratne D; Keem M; Lewis C; Kang M; Walterfang M; Farrand S; Loi S; Kelso W; Cadwallader C; Berkovic SF; Li QX; Masters CL; Collins S; Santillo A; Velakoulis D;
J Neurol Sci; 2022 Nov; 442():120439. PubMed ID: 36201960
[TBL] [Abstract][Full Text] [Related]
11. Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives.
Eratne D; Janelidze S; Malpas CB; Loi S; Walterfang M; Merritt A; Diouf I; Blennow K; Zetterberg H; Cilia B; Wannan C; Bousman C; Everall I; Zalesky A; Jayaram M; Thomas N; Berkovic SF; Hansson O; Velakoulis D; Pantelis C; Santillo A;
Aust N Z J Psychiatry; 2022 Oct; 56(10):1295-1305. PubMed ID: 35179048
[TBL] [Abstract][Full Text] [Related]
12. Serum Neurofilament Light in Patients with Frontotemporal Dementia Caused by CHMP2B Mutation.
Toft A; Roos P; Jääskeläinen O; Musaeus CS; Henriksen EE; Johannsen P; Nielsen TT; Herukka SK; Hviid Simonsen A; Nielsen JE
Dement Geriatr Cogn Disord; 2020; 49(6):533-538. PubMed ID: 33626531
[TBL] [Abstract][Full Text] [Related]
13. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K
JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027
[TBL] [Abstract][Full Text] [Related]
14. A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A 'C-reactive protein' for psychiatrists and neurologists?
Eratne D; Loi SM; Walia N; Farrand S; Li QX; Varghese S; Walterfang M; Evans A; Mocellin R; Dhiman K; Gupta V; Malpas CB; Collins S; Masters CL; Velakoulis D
Aust N Z J Psychiatry; 2020 Jan; 54(1):57-67. PubMed ID: 31220922
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Cerebrospinal Fluid Neurofilament Light Chain as a Routine Biomarker in a Memory Clinic.
Niikado M; Chrem-Méndez P; Itzcovich T; Barbieri-Kennedy M; Calandri I; Martinetto H; Serra M; Calvar J; Campos J; Russo MJ; Pertierra L; Allegri R; Sevlever G; Surace EI
J Gerontol A Biol Sci Med Sci; 2019 Mar; 74(4):442-445. PubMed ID: 30107413
[TBL] [Abstract][Full Text] [Related]
16. Plasma neurofilament light protein correlates with diffusion tensor imaging metrics in frontotemporal dementia.
Spotorno N; Lindberg O; Nilsson C; Landqvist Waldö M; van Westen D; Nilsson K; Vestberg S; Englund E; Zetterberg H; Blennow K; Lätt J; Markus N; Lars-Olof W; Alexander S
PLoS One; 2020; 15(10):e0236384. PubMed ID: 33108404
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in the psychiatric presentation of behavioural variant frontotemporal dementia (bvFTD).
Bretag-Norris R; Gallur L; Flynn P
Australas Psychiatry; 2019 Oct; 27(5):491-495. PubMed ID: 31310153
[TBL] [Abstract][Full Text] [Related]
18. The role of neurofilament light chain in frontotemporal dementia: a meta-analysis.
Karantali E; Kazis D; Chatzikonstantinou S; Petridis F; Mavroudis I
Aging Clin Exp Res; 2021 Apr; 33(4):869-881. PubMed ID: 32306372
[TBL] [Abstract][Full Text] [Related]
19. Bipolar Disorder Among Patients Diagnosed With Frontotemporal Dementia.
Mendez MF; Parand L; Akhlaghipour G
J Neuropsychiatry Clin Neurosci; 2020; 32(4):376-384. PubMed ID: 32498603
[TBL] [Abstract][Full Text] [Related]
20. Clinical Accuracy of Serum Neurofilament Light to Differentiate Frontotemporal Dementia from Primary Psychiatric Disorders is Age-Dependent.
Light V; Jones SL; Rahme E; Rousseau K; de Boer S; Vermunt L; Soltaninejad M; Teunissen C; Pijnenburg Y; Ducharme S; Consortium FS
Am J Geriatr Psychiatry; 2024 Mar; ():. PubMed ID: 38609836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
